Clinical Research:
University of New Mexico Psilocybin in the Treatment of Alcoholism
Harbor - UCLA Psilocybin & Cancer
New York University Psilocybin & Cancer
Johns Hopkins University Psilocybin & Cancer
Psilocybin in the Treatment of Obsessive-Compulsive Disorder
Basic Science Research:
Heffter-Zürich Center Psilocybin-Serotonin Receptor Research
Johns Hopkins University Psilocybin & Spirituality
Preclinical Research:
Behavioral, Molecular and Genetic Research
University of New Mexico

University of New Mexico

Support research like this: arrow

ALL HEFFTER SUPPORTED
RESEARCH arrow
OUR BOARD OF DIRECTORS arrow

Psilocybin in the Treatment of Alcoholism

divider

The goal of this program of research is to determine whether the classic hallucinogen psilocybin is effective in the treatment of alcoholism when administered in the context of appropriate therapy and support. 

In the first stage of this research, an open-label pilot study with 10 participants is being conducted to establish an appropriate dose range for use of psilocybin in alcohol dependent participants, demonstrate the feasibility of the treatment, and provide preliminary outcome and safety data.

The intervention comprises two psilocybin administration sessions and a total of 12 psychosocial treatment sessions including preparation, debriefing, and Motivational Enhancement Therapy (MET: a structured approach using the principles of Motivational Interviewing). This study is the first trial of psilocybin in the treatment of alcohol use disorder. 

Recruitment for this pilot study has been completed, and the study is now in the follow-up phase. The protocol for a double-blind trial is now in development. 

For more information, please contact Research Coordinator Jessica Pommy at 505-925-4190, or email Michael Bogenschutz, M.D. at mbogenschutz@salud.unm.edu.